Quick-Med Tech announces advances in patent coverage for NIMBUS ® technology
Life Sciences Company Quick-Med Technologies Inc has announced advances in patent coverage in China, Australia, and Mexico for its novel, non-leaching NIMBUS ® antimicrobial technology.
The Australian Patent Office and the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial have given the company pending patent entitled Disinfectant with Quaternary Ammonium Polymer and Copolymers in their respective jurisdictions, the news reports said.
The State Intellectual Property of the People’s Republic of China has also issued a notification to grant an invention patent for this pending patent in China.
The patents will expand the international intellectual property coverage for NIMBUS, the news reports said. NIMBUS technology includes the chemistry of antimicrobials that comprise a high charge density polycation built into the backbone of various polymers.
The new patents are the key composition of matter patents that cover the incorporation of a NIMBUS polycation into the main chain of a urethane polymer. The patents also provides protection for various claims regarding the efficacy and durability of an antimicrobial polyurethane.
Dr. William Toreki, co-inventor and Quick-Med’s Vice President of Research & Development said, “This patent adds an exciting new dimension to our NIMBUS technology.”
Quick-Med Technologies is a life sciences company engaged in developing proprietary, broad-based technologies to prevent infection and control the consumer and healthcare markets. The company commercialized its NIMBUS technology in traditional wound care products in 2009 and is also developing NIMBUS applications in other medical device areas including adhesives, foams, hydrogels, films, hydrocolloids, and catheters.
